Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,110.00
-25.00 (-0.60%)
At close: Aug 11, 2026

Cellromax Science Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
45,37873,57457,231
Market Cap Growth
-27.64%28.56%-
Enterprise Value
36,49868,367-
Last Close Price
4110.006361.124650.24

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
PE Ratio
13.6024.8014.99
PS Ratio
2.163.322.65
PB Ratio
0.951.571.29
P/TBV Ratio
1.011.671.39
P/FCF Ratio
22.1243.119.40
P/OCF Ratio
21.3141.219.09

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
EV/Sales Ratio
1.743.08-
EV/EBITDA Ratio
13.0020.63-
EV/EBIT Ratio
15.6624.11-
EV/FCF Ratio
17.7940.06-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
Debt / Equity Ratio
0.010.010.03
Debt / EBITDA Ratio
0.140.140.25
Debt / FCF Ratio
0.190.280.25
Net Debt / Equity Ratio
-0.19-0.15-0.48
Net Debt / EBITDA Ratio
-3.16-2.18-3.58
Net Debt / FCF Ratio
-4.33-4.23-3.49
Asset Turnover
0.420.44-
Inventory Turnover
2.282.14-
Quick Ratio
3.213.087.41
Current Ratio
4.875.209.10
Return on Equity (ROE)
7.58%6.49%-
Return on Assets (ROA)
2.89%3.54%-
Return on Invested Capital (ROIC)
5.94%7.74%17.55%
Return on Capital Employed (ROCE)
4.80%5.90%12.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
Earnings Yield
7.53%4.03%6.67%
FCF Yield
4.52%2.32%10.64%
Payout Ratio
61.23%114.25%-
Buyback Yield / Dilution
-5.97%-9.70%-